–
Cogent Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.6
FY22:
−148
FY23:
−208
FY24:
−276
FY25:
−333
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.6
FY22:
−142
FY23:
−205
FY24:
−272
FY25:
−314
(positive)
Change from FY21 to FY25
millions USD
FY21:
−72.3
FY22:
−140
FY23:
−192
FY24:
−256
FY25:
−329
(positive)
Change from FY21 to FY25
millions USD
FY21:
−72.3
FY22:
−140
FY23:
−192
FY24:
−256
FY25:
−329
All amounts in millions USD